Cost-Effectiveness Analysis of Rivaroxaban in Chinese Patients With Stable Cardiovascular Disease

• Autori principali: Tianyu Feng (Autore), Zhou Zheng (Autore), Shang Gao (Autore), Jiaying Xu (Autore), Pen Cao (Autore), Huanhuan Jia (Autore), Xihe Yu (Autore)
• Natura: Libro
• Pubblicazione: Frontiers Media S.A., 2022-06-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Objective: This study aimed to investigate the cost-effectiveness of low-dose rivaroxaban plus aspirin versus aspirin alone for patients with stable cardiovascular diseases in the China.Methods: We used TreeAge 2019 to construct a Markov model to assess the direct healthcare costs and quality-adjust...